2007 NSTI Nanotechnology Conference and Trade Show - Nanotech 2007 - 10th Annual

Characterization and in vivo efficacy of targeted nanoparticles for systemic siRNA delivery to tumors

D.W. Bartlett and M.E. Davis
California Institute of Technology, US

siRNA, transferrin targeting, systemic delivery, bioluminescent imaging

This abstract highlights the results from our latest work in the design and application of targeted nanoparticles for systemic siRNA delivery. Over the past several years, we have performed extensive physicochemical and biological characterization of the cyclodextrin-containing polycation (CDP) and its complexes with a variety of nucleic acid molecules. As a result of these studies, we are now able to estimate the stoichiometry of an individual nanoparticle, including the number of nucleic acid molecules and the number of targeting ligands. We illustrate how this knowledge can be used to correlate the nanoparticle structure with its biological function. Additionally, we will present our latest findings from in vivo studies looking at the ability of these targeted nanoparticles to deliver therapeutic siRNA to tumors after systemic injection in murine cancer models. Data will also be presented to show the effect of siRNA dosing schedule on the subsequent growth of the tumors, as monitored by bioluminescent imaging.

Back to Program

Sessions Sunday Monday Tuesday Wednesday Thursday Authors Keywords

Nanotech 2007 Conference Program Abstract


Names, and logos of other organizations are the property of those organizations and not of NSTI.
This event is not open to the general public and NSTI reserves the right to refuse admission and participation to any individual.